Goldman Sachs’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-796,286
| Closed | -$47.8M | – | 6838 |
|
|
2021
Q1 | $47.8M | Buy |
796,286
+770,049
| +2,935% | +$27.9M | 0.01% | 1202 |
|
|
2020
Q4 | $390K | Buy |
26,237
+7,744
| +42% | +$108K | ﹤0.01% | 4757 |
|
|
2020
Q3 | $212K | Buy |
+18,493
| New | +$316K | ﹤0.01% | 4888 |
|